Drug Prices
Oct 6, 2020
A recent analysis from the Peterson Center on Healthcare and the Kaiser Family Foundation, “What drives health spending in the U.S. compared to other countries,” does not provide a full picture on health care spending in the U.S. while also downplaying the immense role that drug costs play in…
Aug 8, 2022
The Senate yesterday voted 51-50 to approve the Inflation Reduction Act of 2022 (H.R. 5376), a roughly $700 billion social spending package that includes health care, climate change and tax provisions.
Jun 10, 2022
The Consumer Price Index has had the fastest increase in over 40 years, the Bureau of Labor Statistics reported today.
Jun 8, 2022
Launch prices for new brand-name prescription drugs increased 20% per year between 2008 and 2021, according to a study reported yesterday in JAMA.
Apr 24, 2022
A new AHA report highlights the significant growth in expenses across labor, drugs, and supplies, as well as the impact that rising inflation is having on hospital prices.
Apr 24, 2022
Hospitals appreciate the support and resources that Congress have provided throughout the COVID-19 pandemic; however, additional support is needed to keep hospitals strong so they can continue to provide care to patients and communities.
- Finance & Budgeting
- Cost Management
- Novel Coronavirus (SARS-CoV-2/COVID-19)
- COVID-19: Coverage and Reimbursement
- Workforce
- Nurses
- COVID-19: Supplies and Personal Protective Equipment (PPE)
- Drug Prices
- Workforce Supply and Demand
- Novel Coronavirus (SARS-CoV-2/COVID-19)
- Advocacy & Public Policy
- The Role of Hospitals
Mar 17, 2022
In a statement submitted to the Senate Finance Committee for a hearing on lowering drug prices in Medicare, AHA encouraged Congress to implement policies that would increase generic alternatives and discourage anti-competitive tactics while maintaining incentives to develop innovative new therapies.
Mar 16, 2022
AHA shares proposals to lower Medicare drug prices with congress.
Mar 15, 2022
Pending federal approval, Civica Rx, the nonprofit consortium of U.S. hospitals, plans to manufacture and distribute several generic insulins, continuing its mission to alleviate chronic shortages of inpatient drugs and reduce drug prices.
Mar 1, 2022
Drug companies raised prices faster than inflation for about half of all drugs covered by Medicare between July 2019 and July 2020, according to an analysis released last week by the Kaiser Family Foundation.